<a href=" http://www.disneyconcerts.com/buy-tadalista-20mg.pptx ">tadalista chewable tablets</a> Women with the BRCA1 mutation were 62 percent less likely to develop a second cancer if they took tamoxifen while BRCA2 carriers had a 67 percent lower risk with the drug. Tamoxifen was tied to fewer second cancers whether or not women's original tumors had been estrogen-responsive according to findings published in the Journal of Clinical Oncology. さんの一首